Goldman Sachs maintains a "Buy" rating with a $139 price target. Vandana Singh Bausch & Lomb And Edgewise Therapeutics Are Among Top 7 Mid Cap Stock Gainers Last Week (Sept 15-Sept 21): Are The ...
Some results have been hidden because they may be inaccessible to you